Your browser doesn't support javascript.
loading
Clinical evaluation of medicinal products for acceleration of fracture healing in patients with osteoporosis.
Goldhahn, Jörg; Scheele, Wim H; Mitlak, Bruce H; Abadie, Eric; Aspenberg, Per; Augat, Peter; Brandi, Maria-Luisa; Burlet, Nansa; Chines, Arkadi; Delmas, Pierre D; Dupin-Roger, Isabelle; Ethgen, Dominique; Hanson, Beate; Hartl, Florian; Kanis, John A; Kewalramani, Reshma; Laslop, Andrea; Marsh, David; Ormarsdottir, Sif; Rizzoli, René; Santora, Art; Schmidmaier, Gerhard; Wagener, Michael; Reginster, Jean-Yves.
Afiliação
  • Goldhahn J; Schulthess Clinic Zurich and Clinical Priority Program "Fracture Fixation in Osteoporotic, Bone" of AO Foundation, Davos, Switzerland. Electronic address: joerg.goldhahn@kws.ch.
  • Scheele WH; Wyeth Research, Cambridge, MA, USA.
  • Mitlak BH; Eli Lilly and Company, Indianapolis, IN, USA.
  • Abadie E; Département de l'Enregistrement et des Etudes Cliniques, AFSSAPS, Saint Denis, France.
  • Aspenberg P; Division of Orthopedics and Sports Medicine, Department of Neuroscience and Locomotion, Faculty of Health Sciences, Linköping University, Linkoping, Sweden.
  • Augat P; Biomechanics Laboratory Paracelsus Medical University, Salzburg, Austria; Biomechanics Laboratory Paracelsus Medical University, Salzburg, Austria.
  • Brandi ML; Metabolic Bone Unit, Laboratory of Molecular Genetics, Department of Internal Medicine, University of Florence, Florence, Italy.
  • Burlet N; International Osteoporosis Foundation, Nyon, Switzerland.
  • Chines A; Wyeth Research, Cambridge, MA, USA.
  • Delmas PD; Hôpital Edouard Herriot, Lyon, France.
  • Dupin-Roger I; IRIS-Servier, Paris, France.
  • Ethgen D; Clinical Development, GSK, Philadelphia, PA, USA.
  • Hanson B; AO Clinical Investigation and Documentation, Davos Platz, Davos, Switzerland.
  • Hartl F; F. Hoffmann-La Roche AG, Basel, Switzerland.
  • Kanis JA; Centre for Metabolic Bone Diseases (WHO Collaborating Centre), University of Sheffield Medical School, Sheffield, UK.
  • Kewalramani R; Amgen Inc., Thousand Oaks, CA, USA.
  • Laslop A; AGES PharmMed, Vienna, Austria.
  • Marsh D; Queen's University Belfast, Division of Surgery and Perioperative Care, Department of Orthopaedic Surgery, Musgrave Park Hospital, Stockman's Lane, Belfast, Ulster, UK.
  • Ormarsdottir S; Senior Expert, Icelandic Medicines Control Agency, Seltjarnarnes, Iceland.
  • Rizzoli R; Centre Collaborateur de l'Oms pour la prevention de l'osteoporose, Geneva, Switzerland.
  • Santora A; Merck & Co., Whitehouse Station, NJ, USA.
  • Schmidmaier G; Center for Musculoskeletal Surgery, Charité-Universitätsmedizin Berlin, Germany.
  • Wagener M; Novartis Pharma AG, Basel, Switzerland.
  • Reginster JY; Department of Public Health Sciences, University of Liège, Liège, Belgium, Chairman GREES, President ESCEO.
Bone ; 43(2): 343-347, 2008 Aug.
Article em En | MEDLINE | ID: mdl-18544475
Assuntos
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Osteoporose / Preparações Farmacêuticas / Consolidação da Fratura / Avaliação Pré-Clínica de Medicamentos Tipo de estudo: Clinical_trials / Guideline Aspecto: Patient_preference Limite: Humans Idioma: En Revista: Bone Assunto da revista: METABOLISMO / ORTOPEDIA Ano de publicação: 2008 Tipo de documento: Article País de publicação: Estados Unidos
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Osteoporose / Preparações Farmacêuticas / Consolidação da Fratura / Avaliação Pré-Clínica de Medicamentos Tipo de estudo: Clinical_trials / Guideline Aspecto: Patient_preference Limite: Humans Idioma: En Revista: Bone Assunto da revista: METABOLISMO / ORTOPEDIA Ano de publicação: 2008 Tipo de documento: Article País de publicação: Estados Unidos